Skip to content

Clinical trials

Phase 4 Thromboembolism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Phase: Phase 4 Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20031
20041
20052
20063
20071
20081
20091
20111
20132
20142
20153
20173
20192
20211
20222
20231
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Unknown status5
Recruiting3
Terminated3
Withdrawn2
Not yet recruiting2
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Chao Yang Hospital3
Les Laboratoires des Médicaments Stériles2
University of Calgary2
Asan Medical Center1
Assistance Publique - Hôpitaux de Paris1
Bristol-Myers Squibb1
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa1
Gruppo Oncologico Italiano di Ricerca Clinica1
Hamilton Health Sciences Corporation1
Heart and Diabetes Center North-Rhine Westfalia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism39
Thrombosis11
Hemorrhage9
Venous Thrombosis6
Pulmonary Embolism4
Venous Thromboembolism2
Antiphospholipid Syndrome1
Aortic Valve Disease1
Atherosclerosis1
Atrial Fibrillation1

Trials

Showing 26 to 39 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.